DOCSLIB.ORG

Photodynamic Therapy Induces Autophagy-Mediated Cell Death In

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Photodynamic Therapy Induces Autophagy-Mediated Cell Death In Song et al. Cell Death and Disease (2020) 11:938 https://doi.org/10.1038/s41419-020-03136-y Cell Death & Disease ARTICLE Open Access Photodynamic therapy induces autophagy- mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway Changfeng Song1,WenXu1,HongkunWu2,XiaotongWang1,QianyiGong1,ChangLiu2,JianwenLiu1 and Lin Zhou2 Abstract Evidence has shown that m-THPC and verteporfin (VP) are promising sensitizers in photodynamic therapy (PDT). In addition, autophagy can act as a tumor suppressor or a tumor promoter depending on the photosensitizer (PS) and the cancer cell type. However, the role of autophagy in m-THPC- and VP-mediated PDT in in vitro and in vivo models of human colorectal cancer (CRC) has not been reported. In this study, m-THPC-PDT or VP-PDT exhibited significant phototoxicity, inhibited proliferation, and induced the generation of large amounts of reactive oxygen species (ROS) in CRC cells. From immunoblotting, fluorescence image analysis, and transmission electron microscopy, we found extensive autophagic activation induced by ROS in cells. In addition, m-THPC-PDT or VP-PDT treatment significantly induced apoptosis in CRC cells. Interestingly, the inhibition of m-THPC-PDT-induced autophagy by knockdown of ATG5 or ATG7 substantially inhibited the apoptosis of CRC cells. Moreover, m-THPC- PDT treatment inhibited tumorigenesis of subcutaneous HCT116 xenografts. Meanwhile, antioxidant treatment 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; markedly inhibited autophagy and apoptosis induced by PDT in CRC cells by inactivating JNK signaling. In conclusion, inhibition of autophagy can remarkably alleviate PDT-mediated anticancer efficiency in CRC cells via inactivation of the ROS/JNK signaling pathway. Our study provides evidence for the therapeutic application of m- THPC and VP in CRC. Introduction for patients diagnosed with advanced-stage CRC is as low Colorectal cancer (CRC) is the third leading cause of as 13.1%3. Surgical resection is the main treatment cancer death globally, with a high incidence and mortality method for patients with early stage CRC, while che- rate1. CRC is stratified into two subgroups: early stage motherapy is regarded as the primary treatment option (stage I and II) and advanced-stage (stage III and IV)2. for patients with advanced-stage CRC2,4. Despite the The 5-year survival rate for patients diagnosed with early improvement in the treatment of CRC, the mortality rate stage CRC is approximately 90%, whereas the survival rate of CRC is still high. Thus, there is an urgent need to develop alternative treatments for CRC. Photodynamic therapy (PDT) is a minimally invasive, Correspondence: Jianwen Liu ([email protected])or effective cancer treatment modality that has emerged as Lin Zhou ([email protected]) 1 an alternative or additional approach to chemotherapy State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory 5 of New Drug Design, School of Pharmacy, East China University of Science and and surgery . PDT has been clinically available and Technology, Shanghai 200237, P.R. China approved to treat some types of cancers, such as head and 2 Department of Laboratory Medicine, Changzheng Hospital, Naval Medical neck cancer, non-small cell lung cancer, prostate cancer, University, Shanghai 200003, P.R. China 6–9 These authors contributed equally: Changfeng Song, Wen Xu and colon cancer . PDT involves three primary Edited by G.M. Fimia © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Official journal of the Cell Death Differentiation Association Song et al. Cell Death and Disease (2020) 11:938 Page 2 of 14 components, namely a nontoxic photosensitizer (PS), a cancer cells to PDT33. In this study, we aimed to inves- light source, and oxygen10. During PDT, PSs absorb tigate whether m-THPC-PDT or VP-PDT treatment has visible light and convert energy to surrounding molecular an anticancer effect in CRC cells and explore the roles of oxygen and generate a range of highly reactive oxygen autophagy in PDT treatment in CRC. species (ROS), such as singlet oxygen, superoxide anions, and hydroxyl radicals11,12. High levels of ROS can rapidly Materials and methods cause significant toxicity, which eventually leads to cell Cell culture death via apoptosis, autophagy, and/or necrosis13,14. PSs Human colon cancer cell lines HCT116 and SW480 function as catalysts during the process of PDT15. Meta- were purchased from the American Type Culture Col- tetrahydroxyphenylchlorin (m-THPC) and verteporfin lection (ATCC, USA). HCT116 cells were cultured in (VP) are second-generation photosensitizers that exhibit RPMI 1640 medium (Thermo Fisher Scientific, Waltham, considerable photocytotoxicity to various tumor cells16,17. MA, USA) supplemented with 10% fetal bovine serum Emerging studies have found that m-THPC-PDT and VP- (Thermo Fisher Scientific) and 1% penicillin/streptomycin PDT could be promising therapeutic candidates for the (HyClone, Logan, UT, USA). SW480 cells were main- treatment of human cancers18,19. tained in Dulbecco’s modified Eagle’s medium (Thermo The role of a PS in the PDT process is similar to that of Fisher Scientific) supplemented with 10% fetal bovine chemical catalysts10. It can be excited by specific wave- serum (HyClone) and 1% penicillin/streptomycin. Cells lengths of light and absorb the energy of photons, con- were incubated in a humidified atmosphere of 5% CO2 at verting them from a stable ground state to a high-energy 37 °C. For starvation experiments, cells were washed three excited singlet state. Singlet oxygen generates free radicals times with phosphate-buffered saline (PBS), and once in the process of returning to the ground state, and free with serum-free media, and then incubated with modified radicals react with molecular oxygen to generate ROS20.A Earle’s Balanced Salt Solution medium (Sigma-Aldrich, St. variety of PSs exist in nature, but the PSs used for tumor Louis, MO, USA) containing 1.0 g/L glucose at 37 °C. treatment are demanding: they need to have the char- acteristics of high singlet oxygen yield, non-toxicity, rapid M-THPC-PDT and VP-PDT elimination from the body through metabolism, and easy The chemicals m-THPC and VP were purchased from accumulation in tumor tissues21,22. The PSs used in PDT MedChemExpress (Monmouth Junction, NJ, USA). They can be divided into porphyrin derivative PS, chlorophyll- were dissolved in DMSO as a 10 mmol/L stock solution derivative PS, and synthetic compound PS23. According to and stored at −80 °C, protected from light. Working the time of occurrence, it can be divided into first-gen- solutions of m-THPC were prepared fresh at various eration, second-generation, and third-generation PS24. concentrations (0, 0.375, 0.75, 1.5, 3.0, 6.0, and 12.0 μmol/ Choosing the right PS to treat a specific disease is parti- L) and working solutions of VP were prepared fresh at cularly critical. The properties of PS, such as charge and various concentrations (0, 0.375, 0.75, 1.5, 3.0, and polarity, are critical to their cellular localization, dis- 6.0 μmol/L), which were activated by a halogen lamp in tribution in the body, and therapeutic efficacy. Many PSs cell experiments, a laser power density of 10 mW/cm2 and selectively accumulate in specific organelles, such as late laser energy densities of 3 J/cm2. endosomes, lysosomes, mitochondria, or the endoplasmic reticulum25. In this case, light causes photo damage to Cell viability assay specific organelles. Therefore, determining the location of An MTT Cell Proliferation and Cytotoxicity Assay Kit the PS in the cell will provide a better understanding of (Beyotime Biotechnology, Shanghai, China) was used to the site of action of phototoxicity26. determine cell viability. HCT116 and SW480 cells (6 × Autophagy is a successive process of degrading and 103 cells per well) were seeded into 96-well plates and renewing cytoplasmic components27. In addition, it is incubated overnight at 37 °C. After that, HCT116 and critical for maintaining homeostasis and cell growth28. SW480 cells were treated with various concentrations of Evidence has shown that autophagy participates in tumor m-THPC (from 0 to 12.0 μmol/L) or VP (from 0 to progression as well as a response to anticancer thera- 6.0 μmol/L) for 8 h. Next, cells were irradiated with a pies29. It has also been shown that photodamage can lead light dose of 3 J/cm2 at a light power density of 10 mW/ to autophagy induction29,30. However, autophagy might cm2, and then incubated for 24 h without irradiation. play dual roles in tumor suppression and promotion Subsequently, cells were incubated with 20 μLof5mg/ depending on the photosensitizers, cell types, and light mL MTT for another 4 h. Subsequently, formazan dose used31. Xiong et al. reported that inhibition of crystals were dissolved using 150 μLofformazandis- autophagy increased photocytotoxicity of Photosan-II in solution reagent. Finally, the optical density value of CRC cells32,33. Meanwhile, Xue et al. indicated that each well at 570 nm was measured using a microplate knockdown of ATG7 enhanced the resistance of breast reader (BioTek, Winooski, VT, USA).
Load more

Recommended publications
  • Autophagy Is a New Protective Mechanism Against the Cytotoxicity
    www.nature.com/scientificreports OPEN Autophagy is a new protective mechanism against the cytotoxicity of platinum nanoparticles in human Received: 14 November 2018 Accepted: 11 February 2019 trophoblasts Published: xx xx xxxx Akitoshi Nakashima1, Kazuma Higashisaka2,3, Tae Kusabiraki1, Aiko Aoki1, Akemi Ushijima1, Yosuke Ono1, Sayaka Tsuda1, Tomoko Shima1, Osamu Yoshino1,7, Kazuya Nagano2, Yasuo Yoshioka2,4,5, Yasuo Tsutsumi2,6 & Shigeru Saito1 Nanoparticles are widely used in commodities, and pregnant women are inevitably exposed to these particles. The placenta protects the growing fetus from foreign or toxic materials, and provides energy and oxygen. Here we report that autophagy, a cellular mechanism to maintain homeostasis, engulfs platinum nanoparticles (nPt) to reduce their cytotoxicity in trophoblasts. Autophagy was activated by nPt in extravillous trophoblast (EVT) cell lines, and EVT functions, such as invasion and vascular remodeling, and proliferation were inhibited by nPt. These inhibitory efects by nPt were augmented in autophagy-defcient cells. Regarding the dynamic state of nPt, analysis using ICP-MS demonstrated a higher accumulation of nPt in the autophagosome-rich than the cytoplasmic fraction in autophagy- normal cells. Meanwhile, there were more nPt in the nuclei of autophagy-defcient cells, resulting in greater DNA damage at a lower concentration of nPt. Thus, we found a new protective mechanism against the cytotoxicity of nPt in human trophoblasts. Pregnant women and developing fetuses are very susceptible to foreign toxins, including air pollutants, microbes, and nanoparticles1–3. Smaller nanoparticles made of silica, titanium dioxide, cobalt and chromium, gold, or silver cross the fetal-maternal barrier more readily than larger particles4–7.
    [Show full text]
  • The Association of ATG16L1 Variations with Clinical Phenotypes of Adult-Onset Still’S Disease
    G C A T T A C G G C A T genes Article The Association of ATG16L1 Variations with Clinical Phenotypes of Adult-Onset Still’s Disease Wei-Ting Hung 1,2, Shuen-Iu Hung 3 , Yi-Ming Chen 4,5,6 , Chia-Wei Hsieh 6,7, Hsin-Hua Chen 6,7,8 , Kuo-Tung Tang 5,6,7 , Der-Yuan Chen 9,10,11,* and Tsuo-Hung Lan 1,5,12,13,* 1 Institute of Clinical Medicine, National Yang-Ming Chiao Tung University, Taipei 11221, Taiwan; [email protected] 2 Department of Medical Education, Taichung Veterans General Hospital, Taichung 40705, Taiwan 3 Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan 33305, Taiwan; [email protected] 4 Department of Medical Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan; [email protected] 5 School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan; [email protected] 6 Rong Hsing Research Center for Translational Medicine & Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 40227, Taiwan; [email protected] (C.-W.H.); [email protected] (H.-H.C.) 7 Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan 8 Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung 40705, Taiwan 9 Translational Medicine Laboratory, Rheumatology and Immunology Center, China Medical University Hospital, Taichung 40447, Taiwan 10 Rheumatology and Immunology Center, China Medical University Hospital, Taichung 40447, Taiwan Citation: Hung, W.-T.; Hung, S.-I.; 11 School of Medicine, China Medical University, Taichung 40447, Taiwan Chen, Y.-M.; Hsieh, C.-W.; Chen, 12 Tsao-Tun Psychiatric Center, Ministry of Health and Welfare, Nantou 54249, Taiwan H.-H.; Tang, K.-T.; Chen, D.-Y.; Lan, 13 Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli 35053, Taiwan T.-H.
    [Show full text]
  • Spermatozoal Gene KO Studies for the Highly Present Paternal Transcripts
    Spermatozoal gene KO studies for the highly present paternal Potential maternal interactions Conclusions of the KO studies on the maternal gene transcripts detected by GeneMANIA candidates for interaction with the paternal Fbxo2 Selective cochlear degeneration in mice lacking Cul1, Fbxl2, Fbxl3, Fbxl5, Cul-1 KO causes early embryonic lethality at E6.5 before Fbxo2 Fbxo34, Fbxo5, Itgb1, Rbx1, the onset of gastrulation http://www.jneurosci.org/content/27/19/5163.full Skp1a http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641602/. Loss of Cul1 results in early embryonic lethality and Another KO study showed the following: Loss of dysregulation of cyclin E F-box only protein 2 (Fbxo2) disrupts levels and http://www.ncbi.nlm.nih.gov/pubmed/10508527?dopt=Abs localization of select NMDA receptor subunits, tract. and promotes aberrant synaptic connectivity http://www.ncbi.nlm.nih.gov/pubmed/25878288. Fbxo5 (or Emi1): Regulates early mitosis. KO studies shown lethal defects in preimplantation embryo A third KO study showed that Fbxo2 regulates development http://mcb.asm.org/content/26/14/5373.full. amyloid precursor protein levels and processing http://www.jbc.org/content/289/10/7038.long#fn- Rbx1/Roc1: Rbx1 disruption results in early embryonic 1. lethality due to proliferation failure http://www.pnas.org/content/106/15/6203.full.pdf & Fbxo2 has been found to be involved in http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732615/. neurons, but it has not been tested for potential decreased fertilization or pregnancy rates. It Skp1a: In vivo interference with Skp1 function leads to shows high expression levels in testis, indicating genetic instability and neoplastic transformation potential other not investigated functions http://www.ncbi.nlm.nih.gov/pubmed/12417738?dopt=Abs http://biogps.org/#goto=genereport&id=230904 tract.
    [Show full text]
  • Paclitaxel Augments Cytotoxic Effect of Photodynamic Therapy Using Verteporfin in Gastric and Bile Duct Cancer Cells
    PAPER www.rsc.org/pps | Photochemical & Photobiological Sciences Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells Seungwoo Park,†a Sung Pil Hong,†a Tae Yoon Oh,b Seungmin Bang,a Jae Bock Chunga and Si Young Song*a,b Received 11th December 2007, Accepted 25th April 2008 First published as an Advance Article on the web 15th May 2008 DOI: 10.1039/b719072g Photodynamic therapy (PDT) shows a limited antitumor effect in treating gastrointestinal tumors because of improper light penetration or insufficient photosensitizer uptake. The aim of this study was to evaluate the cytotoxic effect of PDT combined with paclitaxel on in vitro cancer cells. In vitro photodynamic therapy was performed in gastric cancer cells (NCI-N87) and bile duct cancer cells (YGIC-6B) using verteporfin (2 ug mL−1) and a PTH light source (1 000 W, Oriel Co.) with 665–675 nm narrow band pass filter. Cytotoxicity was compared using the MTT assay between cancer cells treated with PDT alone or pretreated with paclitaxel (IC25). Apoptotic changes were evaluated using DAPI staining, DNA fragmentation analysis, Annexin V-FITC apoptosis assay, cell cycle analysis, and western blots for cytochrome c, Bax, and Bid. The PDT-induced cytotoxicity was potentiated by pretreating with low dose paclitaxel (P < 0.001). The enhanced cytotoxicity was due to an augmented apoptotic response mediated by exaggerated cytochrome c released from mitochondria, without Bax or Bid activation. These results show that paclitaxel pretreatment
    [Show full text]
  • Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer
    cancers Article Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer Ting Luo 1, Qinrong Zhang 1,* and Qing-Bin Lu 1,2,* 1 Department of Physics and Astronomy, University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada; [email protected] 2 Departments of Biology and Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada * Correspondence: [email protected] (Q.Z.); [email protected] (Q.-B.L.); Tel.: +1-519-888-4567 (ext. 33503) (Q.-B.L.) Academic Editor: Michael R. Hamblin Received: 12 May 2017; Accepted: 1 June 2017; Published: 5 June 2017 Abstract: Indocyanine green (ICG) has been reported as a potential near-infrared (NIR) photosensitizer for photodynamic therapy (PDT) of cancer. However the application of ICG-mediated PDT is both intrinsically and physiologically limited. Here we report a combination of ICG-PDT with a chemotherapy drug etoposide (VP-16), aiming to enhance the anticancer efficacy, to circumvent limitations of PDT using ICG, and to reduce side effects of VP-16. We found in controlled in vitro cell-based assays that this combination is effective in killing non-small-cell lung cancer cells (NSCLC, A549 cell line). We also found that the combination of ICG-PDT and VP-16 exhibits strong synergy in killing non-small-cell lung cancer cells partially through inducing more DNA double-strand breaks (DSBs), while it has a much weaker synergy in killing human normal cells (GM05757). Furthermore, by studying the treatment sequence dependence and the cytotoxicity of laser-irradiated mixtures of ICG and VP-16, we found that the observed synergy involves direct/indirect reactions between ICG and VP-16.
    [Show full text]
  • And Inflammation-Related Gene Expression in White Blood
    cells Article Post-Effort Changes in Autophagy- and Inflammation-Related Gene Expression in White Blood Cells of Healthy Young Men Dorota Kostrzewa-Nowak 1,* , Alicja Trzeciak-Ryczek 2,3, Paweł Wityk 4 , Danuta Cembrowska-Lech 2,3 and Robert Nowak 1 1 Centre for Human Structural and Functional Research, Institute of Physical Culture Sciences, University of Szczecin, 17C Narutowicza St., 70-240 Szczecin, Poland; [email protected] 2 Institute of Biology, University of Szczecin, 13 W ˛askaSt., 71-415 Szczecin, Poland; [email protected] (A.T.-R.); [email protected] (D.C.-L.) 3 The Centre for Molecular Biology and Biotechnology, University of Szczecin, 13 W ˛askaSt., 71-415 Szczecin, Poland 4 Faculty of Chemistry, Gda´nskUniversity of Technology, 11/12 Narutowicza St., 80-233 Gda´nsk,Poland; [email protected] * Correspondence: [email protected] Abstract: Acute, strenuous physical exertion requiring high levels of energy production induces the production of reactive oxygen species and metabolic disturbances that can damage the mitochondria. Thus, selective autophagic elimination of defective mitochondria may improve resistance to oxidative stress and potentially to inflammation. The main goal of this study was to evaluate the impacts of intense effort on changes in the expression of select genes related to post-effort inflammation and autophagy. Thirty-five men aged 16–21 years were recruited to the study. The impacts of both aerobic Citation: Kostrzewa-Nowak, D.; (endurance) and anaerobic (speed) efforts on selected genes encoding chemokines (CXCL5, 8–12) Trzeciak-Ryczek, A.; Wityk, P.; were analyzed.
    [Show full text]
  • Targeting Phosphatidylinositol 3-Kinase Signaling Pathway For
    Published OnlineFirst August 23, 2017; DOI: 10.1158/1535-7163.MCT-17-0326 Small Molecule Therapeutics Molecular Cancer Therapeutics Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy Daniel Kraus1, Pratheeba Palasuberniam1, and Bin Chen1,2 Abstract Vascular-targeted photodynamic therapy (PDT) selectively the strongest synergism, followed in order by combinations disrupts vascular function by inducing oxidative damages to with pan-PI3K inhibitor BKM120 and p110a isoform-selective the vasculature, particularly endothelial cells. Although effec- inhibitor BYL719. Combination treatments of PDT and tive tumor eradication and excellent safety profile are well BEZ235 exhibited a cooperative inhibition of antiapoptotic demonstrated in both preclinical and clinical studies, incom- Bcl-2 family protein Mcl-1 and induced more cell apoptosis plete vascular shutdown and angiogenesis are known to cause than each treatment alone. In addition to increasing treatment tumor recurrence after vascular-targeted PDT. We have explored lethality, BEZ235 combined with PDT effectively inhibited therapeutic enhancement of vascular-targeted PDT with PI3K PI3K pathway activation and consequent endothelial cell pro- signaling pathway inhibitors because the activation of PI3K liferation after PDT alone, leading to a sustained growth inhi- pathway was involved in promoting endothelial cell survival bition. In the PC-3 prostate tumor model, combination treat- and proliferation after PDT. Here, three clinically relevant ments improved treatment outcomes by turning a temporary small-molecule inhibitors (BYL719, BKM120, and BEZ235) of tumor regrowth delay induced by PDT alone to a more long- the PI3K pathway were evaluated in combination with verte- lasting treatment response. Our study strongly supports the porfin-PDT.
    [Show full text]
  • Identification of a Novel Autophagy-Related Gene Signature
    Identication of a novel autophagy-related gene signature for predicting metastasis and survival in patients with osteosarcoma Guangzhi Zhang Lanzhou University Second Hospital https://orcid.org/0000-0003-3193-0297 Yajun Deng Lanzhou University Second Hospital Zuolong Wu Lanzhou University Second Hospital Enhui Ren Lanzhou University Second Hospital Wenhua Yuan Lanzhou University Second Hospital Qiqi Xie ( [email protected] ) Lanzhou University Second Hospital https://orcid.org/0000-0003-4099-5287 Primary research Keywords: osteosarcoma, autophagy-related genes, signature, survival, metastasis Posted Date: March 26th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-19384/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/20 Abstract Background: Osteosarcoma (OS) is a bone malignant tumor that occurs in children and adolescents. Due to a lack of reliable prognostic biomarkers, the prognosis of OS patients is often uncertain. This study aimed to construct an autophagy-related gene signature to predict the prognosis of OS patients. Methods: The gene expression prole data of OS and normal muscle tissue samples were downloaded separately from the Therapeutically Applied Research To Generate Effective Treatments (TARGET) and Genotype-Tissue Expression (GTEx) databases . The differentially expressed autophagy-related genes (DEARGs) in OS and normal muscle tissue samples were screened using R software, before being subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. A protein-protein interaction (PPI) network was constructed and hub autophagy-related genes were screened. Finally, the screened autophagy-related genes were subjected to univariate Cox regression, Lasso Cox regression, survival analysis, and clinical correlation analysis.
    [Show full text]
  • The Mtorc1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
    The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4 The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Csibi, Alfred, Sarah-Maria Fendt, Chenggang Li, George Poulogiannis, Andrew Y. Choo, Douglas J. Chapski, Seung Min Jeong, et al. “The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4.” Cell 153, no. 4 (May 2013): 840–854. © 2013 Elsevier Inc. As Published http://dx.doi.org/10.1016/j.cell.2013.04.023 Publisher Elsevier Version Final published version Citable link http://hdl.handle.net/1721.1/91506 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4 Alfred Csibi,1 Sarah-Maria Fendt,2,6 Chenggang Li,3,5 George Poulogiannis,4,5 Andrew Y. Choo,1 Douglas J. Chapski,1 Seung Min Jeong,1 Jamie M. Dempsey,1 Andrey Parkhitko,3 Tasha Morrison,3 Elizabeth P. Henske,3 Marcia C. Haigis,1 Lewis C. Cantley,4 Gregory Stephanopoulos,2 Jane Yu,3 and John Blenis1,* 1Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA 2Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 3Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA 4Division of Signal Transduction,
    [Show full text]
  • Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
    Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Current Effective Date: MM.02.016 March 22, 2019 Lines of Business: Original Effective Date: HMO; PPO; QUEST Integration April 01, 2008 Place of Service: Precertification: Office Not Required I. Description Photodynamic therapy (PDT) refers to light activation of a photosensitizer to generate highly reactive intermediaries, which ultimately cause tissue injury and necrosis. Photosensitizing agents are being proposed for use with dermatologic conditions such as actinic keratoses and nonmelanoma skin cancers.For individuals who have nonhyperkeratotic actinic keratoses on the face or scalp who receive PDT, the evidence includes randomized controlled trials (RCTs). The relevant outcomes are symptoms, change in disease status, quality of life, and treatment-related morbidity. Evidence from multiple RCTs has found that PDT improves the net health outcome in patients with nonhyperkeratotic actinic keratoses on the face or scalp compared with placebo or other active interventions. The evidence is sufficient to determine that the technology results in a meaningful improvement in the net health outcome. For individuals who have low-risk basal cell carcinoma who receive PDT, the evidence includes RCTs and systematic reviews of RCTs. The relevant outcomes are symptoms, change in disease status, quality of life, and treatment-related morbidity. Systematic reviews of RCTs have found that PDT may not be as effective as surgery for superficial and nodular basal cell carcinoma. In the small number of trials available, PDT was more effective than placebo. The available evidence from RCTs has suggested that PDT has better cosmetic outcomes than surgery.
    [Show full text]
  • Mtor Signaling in Metabolism and Cancer
    cells Editorial mTOR Signaling in Metabolism and Cancer Shile Huang 1,2 1 Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA; [email protected]; Tel.: +1-318-675-7759 2 Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA Received: 10 October 2020; Accepted: 13 October 2020; Published: 13 October 2020 Abstract: The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in this special issue summarize the current understanding of the mTOR pathway and its role in the regulation of tissue regeneration, regulatory T cell differentiation and function, and different types of cancer including hematologic malignancies, skin, prostate, breast, and head and neck cancer. The findings highlight that targeting the mTOR pathway is a promising strategy to fight against certain human diseases. Keywords: mTOR; PI3K; Akt; tissue regeneration; regulatory T cells; tumor; photodynamic therapy The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, integrates environmental cues such as hormones, growth factors, nutrients, oxygen, and energy, regulating cell growth, proliferation, survival, motility and differentiation as well as metabolism (reviewed in [1,2]). Evidence has demonstrated that deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases (reviewed in [1,2]). Current knowledge indicates that mTOR functions at least as two distinct complexes (mTORC1 and mTORC2) in mammalian cells.
    [Show full text]
  • Identification of Protein Features Encoded by Alternative Exons Using Exon Ontology
    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Resource Identification of protein features encoded by alternative exons using Exon Ontology Léon-Charles Tranchevent,1 Fabien Aubé,1 Louis Dulaurier,1 Clara Benoit-Pilven,1 Amandine Rey,1 Arnaud Poret,1 Emilie Chautard,2 Hussein Mortada,1 François-Olivier Desmet,1 Fatima Zahra Chakrama,1 Maira Alejandra Moreno-Garcia,1 Evelyne Goillot,3 Stéphane Janczarski,1 Franck Mortreux,1 Cyril F. Bourgeois,1,4 and Didier Auboeuf1,4 1Université Lyon 1, ENS de Lyon, CNRS UMR 5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, F-69007, Lyon, France; 2Laboratoire de Biométrie et Biologie Évolutive, Université Lyon 1, UMR CNRS 5558, INRIA Erable, Villeurbanne, F-69622, France; 3Institut NeuroMyoGène, CNRS UMR 5310, INSERM U1217, Université Lyon 1, Lyon, F-69007 France Transcriptomic genome-wide analyses demonstrate massive variation of alternative splicing in many physiological and pathological situations. One major challenge is now to establish the biological contribution of alternative splicing var- iation in physiological- or pathological-associated cellular phenotypes. Toward this end, we developed a computational approach, named Exon Ontology, based on terms corresponding to well-characterized protein features organized in an ontology tree. Exon Ontology is conceptually similar to Gene Ontology-based approaches but focuses on exon-encod- ed protein features instead of gene level functional annotations. Exon Ontology describes the protein features encoded by a selected list of exons and looks for potential Exon Ontology term enrichment. By applying this strategy to exons that are differentially spliced between epithelial and mesenchymal cells and after extensive experimental validation, we demonstrate that Exon Ontology provides support to discover specific protein features regulated by alternative splic- ing.
    [Show full text]